BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TherOx 

2400 Michelson Drive

Irvine  California  92612-1310  U.S.A.
Phone: 949-757-1999 Fax: 949-757-1989


SEARCH JOBS





Segment
Research





 Company News
TherOx Seeks $25 Million In Final Push For Medtech To Reduce Infarct Size In Heart Attack Patients 12/2/2013 8:31:04 AM
TherOx Release: Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System 11/4/2013 12:56:30 PM
TherOx Announces Presentation of Supersaturated Oxygen Therapy IDE Study Results at TCT 2013 10/15/2013 6:48:16 AM
TherOx Completes Next-Generation Supersaturated Oxygen Therapy IDE Pilot Study for AMI 9/11/2013 9:59:49 AM
Medical Device TherOx Cancels IPO 2/4/2009 7:11:58 AM
Medical Device Firm TherOx Files for $100 Million IPO 9/5/2008 6:45:13 AM
TherOx Raises $30 Million in Preferred Equity Financing 3/4/2008 8:24:33 AM
TherOx AMIHOT II Pivotal Trial Meets Endpoints 10/23/2007 11:45:02 AM
TherOx's AMIHOT: Data Supports New Heart Attack Treatment For Reducing Infarct Size; Investigators Present Clinical Trial Results At TCT 200410/19/2005 5:11:48 PM
TherOx Raises $30 Million in Preferred Equity Financing10/19/2005 5:11:39 PM